Literature DB >> 16086920

Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes.

Xavier Bosch1, Pierre Théroux.   

Abstract

BACKGROUND: Improvement in risk stratification of patients with non-ST-segment elevation acute coronary syndrome (ACS) is a gateway to a more judicious treatment. This study examines whether the routine determination of left ventricular ejection fraction (EF) adds significant prognostic information to currently recommended stratifiers.
METHODS: Several predictors of inhospital mortality were prospectively characterized in a registry study of 1104 consecutive patients, for whom an EF was determined, who were admitted for an ACS. Multiple regression models were constructed using currently recommended clinical, electrocardiographic, and blood marker stratifiers, and values of EF were incorporated into the models.
RESULTS: Age, ST-segment shifts, elevation of cardiac markers, and the Thrombolysis in Myocardial Infarction (TIMI) risk score all predicted mortality (P < .0001). Adding EF into the model improved the prediction of mortality (C statistic 0.73 vs 0.67). The odds of death increased by a factor of 1.042 for each 1% decrement in EF. By receiver operating curves, an EF cutoff of 48% provided the best predictive value. Mortality rates were 3.3 times higher within each TIMI risk score stratum in patients with an EF of 48% or lower as compared with those with higher.
CONCLUSIONS: The TIMI risk score predicts inhospital mortality in a broad population of patients with ACS. The further consideration of EF adds significant prognostic information.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086920     DOI: 10.1016/j.ahj.2004.09.027

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction.

Authors:  Jeanna C Perman; Pontus Boström; Malin Lindbom; Ulf Lidberg; Marcus StÅhlman; Daniel Hägg; Henrik Lindskog; Margareta Scharin Täng; Elmir Omerovic; Lillemor Mattsson Hultén; Anders Jeppsson; Petur Petursson; Johan Herlitz; Gunilla Olivecrona; Dudley K Strickland; Kim Ekroos; Sven-Olof Olofsson; Jan Borén
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

2.  Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.

Authors:  Xue-Biao Wei; Yuan-Hui Liu; Peng-Cheng He; Lei Jiang; Ying-Ling Zhou; Ji-Yan Chen; Ning Tan; Dan-Qing Yu
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

3.  Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans.

Authors:  John H Eisenach; Darrell R Schroeder; Tasha L Pike; Christopher P Johnson; William G Schrage; Eric M Snyder; Bruce D Johnson; Vesna D Garovic; Stephen T Turner; Michael J Joyner
Journal:  J Physiol       Date:  2006-06-01       Impact factor: 5.182

4.  Left ventricular ejection fraction measurements: accuracy and prognostic implications in a large population of patients with known or suspected ischemic heart disease.

Authors:  Alessia Gimelli; Patrizia Landi; Paolo Marraccini; Rosa Sicari; Paolo Frumento; Antonio L'Abbate; Daniele Rovai
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-09       Impact factor: 2.357

5.  Clinical predictors of late death in survivors of acute myocardial infarction.

Authors:  Sunil Kumar Agarwal; Ish Singla; Haitham Hreybe; Samir Saba
Journal:  Tex Heart Inst J       Date:  2009

6.  Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention.

Authors:  Tuncay Kırıs; Eyüp Avcı; Aykan Çelik
Journal:  BMC Cardiovasc Disord       Date:  2018-03-02       Impact factor: 2.298

7.  Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: A real world study.

Authors:  Olga Perelshtein Brezinov; Robert Klempfner; Sagit Ben Zekry; Ilan Goldenberg; Rafael Kuperstein
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Left ventricular ejection fraction adds value over the GRACE score in prediction of 6-month mortality after ACS: the MADDEC study.

Authors:  Nina Syyli; Markus Hautamäki; Kari Antila; Shadi Mahdiani; Markku Eskola; Terho Lehtimäki; Kjell Nikus; Leo-Pekka Lyytikäinen; Niku Oksala; Jussi Hernesniemi
Journal:  Open Heart       Date:  2019-06-27

9.  Effect of left ventricular ejection fraction on the prognostic impact of chronic total occlusion in a non-infarct-related artery in patients with acute myocardial infarction.

Authors:  Hiromasa Ito; Jun Masuda; Tairo Kurita; Mizuki Ida; Ayato Yamamoto; Akihiro Takasaki; Tetsushiro Takeuchi; Yuichi Sato; Takashi Omura; Toshiki Sawai; Takashi Tanigawa; Masaaki Ito; Kaoru Dohi
Journal:  Int J Cardiol Heart Vasc       Date:  2021-02-26

10.  Predictors of all-cause 1-year mortality in myocardial infarction patients.

Authors:  Qing Ye; Jie Zhang; Likun Ma
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.